Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma. (July 2022)

Record Type:
Journal Article
Title:
Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma. (July 2022)
Main Title:
Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma
Authors:
Ma, Pei
Shen, Hao-Yang
Chen, Dong-Sheng
Lu, Zhong-Yu
Gao, Wen
Shu, Yong-Qian
Abstract:
Is Part Of:
Oral oncology. Volume 130(2022)
Journal:
Oral oncology
Issue:
Volume 130(2022)
Issue Display:
Volume 130, Issue 2022 (2022)
Year:
2022
Volume:
130
Issue:
2022
Issue Sort Value:
2022-0130-2022-0000
Page Start:
Page End:
Publication Date:
2022-07
Subjects:
Mouth -- Cancer -- Periodicals
Mouth -- Tumors -- Periodicals
Mouth Diseases -- Periodicals
Mouth Neoplasms -- Periodicals
Bouche -- Cancer -- Périodiques
Bouche -- Tumeurs -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9943105
Journal URLs:
http://www.sciencedirect.com/science/journal/13688375 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/13688375 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.oraloncology.2022.105905 ↗
Languages:
English
ISSNs:
1368-8375
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 6277.592000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21792.xml